Clinical trial
Combination Chemotherapy for Patients With Brain Cancer
NCT00002814 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00002814 |
|---|---|
| Title | Combination Chemotherapy for Patients With Brain Cancer |
| Official title | A Phase II Trial of Paclitaxel and Topotecan With Filgrastim in Patients With Recurrent or Refractory Glioblastoma Multiforme or Anaplastic Astrocytoma |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, paclitaxel, topotecan hydrochloride |
| Enrollment | 20 |
| Start date | Aug 1, 1996 |
| Primary completion | Apr 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Apr 6, 2004 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: